ID: ALA348958

Max Phase: Preclinical

Molecular Formula: C10H10N4O2

Molecular Weight: 218.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1nc(NCc2ccccc2)[nH]c(=O)[nH]1

Standard InChI:  InChI=1S/C10H10N4O2/c15-9-12-8(13-10(16)14-9)11-6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,11,12,13,14,15,16)

Standard InChI Key:  NICDNOIBRSLZKW-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 218.22Molecular Weight (Monoisotopic): 218.0804AlogP: 0.07#Rotatable Bonds: 3
Polar Surface Area: 90.64Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.17CX Basic pKa: 2.12CX LogP: 0.58CX LogD: -1.19
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: -1.03

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source